Hagens Berman Reminds Telix Investors of Class Action Deadline Amid SEC and FDA Challenges Hagens Berman urges Telix investors to act by January 9 to join a class action lawsuit regarding manufacturing failures and SEC inquiries, following a notable stock drop.

Hagens Berman Reminds Telix Investors of Class Action Deadline Amid SEC and FDA Challenges #None #Telix_Pharmaceuticals #Hagens_Berman #TLX591

Hagens Berman Encourages Telix Investors to Join Lawsuit by January 9 Over Alleged Regulatory Failures Hagens Berman reminds Telix investors of the January 9 deadline to seek lead plaintiff status in a lawsuit related to alleged regulatory missteps impacting stock value.

Hagens Berman Encourages Telix Investors to Join Lawsuit by January 9 Over Alleged Regulatory Failures #USA #San_Francisco #SEC_Investigation #Telix_Pharmaceuticals #TLX591

Hagens Berman Alerts Telix Investors: Key Lawsuit Deadline Approaching Amid Regulatory Issues As Telix faces legal action due to serious regulatory failures, investors are urged to act by January 9. Hagens Berman highlights crucial developments.

Hagens Berman Alerts Telix Investors: Key Lawsuit Deadline Approaching Amid Regulatory Issues #United_States #San_Francisco #Telix #Hagens_Berman #TLX591